Clean Energy Fuels Corp. (CLNE) EPS Estimated At $-0.11; SANUWAVE HEALTH (SNWV) Sellers Decreased By 85.74% Their Shorts

February 24, 2018 - By Adrian Erickson

SANUWAVE HEALTH INC (OTCMKTS:SNWV) had a decrease of 85.74% in short interest. SNWV’s SI was 29,600 shares in February as released by FINRA. Its down 85.74% from 207,600 shares previously. With 395,300 avg volume, 0 days are for SANUWAVE HEALTH INC (OTCMKTS:SNWV)’s short sellers to cover SNWV’s short positions. The SI to SANUWAVE HEALTH INC’s float is 0.03%. The stock increased 8.33% or $0.025 during the last trading session, reaching $0.325. About 640,671 shares traded or 69.33% up from the average. SANUWAVE Health, Inc. (OTCMKTS:SNWV) has 0.00% since February 24, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts expect Clean Energy Fuels Corp. (NASDAQ:CLNE) to report $-0.11 EPS on March, 13 after the close.They anticipate $0.08 EPS change or 266.67% from last quarter’s $-0.03 EPS. After having $-0.62 EPS previously, Clean Energy Fuels Corp.’s analysts see -82.26% EPS growth. The stock decreased 0.69% or $0.01 during the last trading session, reaching $1.43. About 519,087 shares traded. Clean Energy Fuels Corp. (NASDAQ:CLNE) has declined 16.50% since February 24, 2017 and is downtrending. It has underperformed by 33.20% the S&P500.

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic pressure shockwaves for regenerative medicine and other applications. The company has market cap of $45.26 million. The Company’s shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It currently has negative earnings. The companyÂ’s lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers.

Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets in the United States and Canada. The company has market cap of $216.05 million. The firm supplies compressed natural gas , liquefied natural gas (LNG), and renewable natural gas (RNG) for light, medium, and heavy-duty vehicles. It currently has negative earnings. It also designs, builds, operates, and maintains fueling stations.

Investors sentiment decreased to 1.35 in 2017 Q3. Its down 0.06, from 1.41 in 2017Q2. It turned negative, as 11 investors sold Clean Energy Fuels Corp. shares while 29 reduced holdings. 15 funds opened positions while 39 raised stakes. 52.96 million shares or 3.31% more from 51.27 million shares in 2017Q2 were reported. Nj State Employees Deferred Compensation Plan holds 30,000 shares or 0.01% of its portfolio. Tradewinds Cap Llc holds 100 shares or 0% of its portfolio. 215,000 were accumulated by Bridgeway Mngmt. Everett Harris & Ca reported 0% in Clean Energy Fuels Corp. (NASDAQ:CLNE). Ameritas Inv Prtnrs Incorporated has invested 0% of its portfolio in Clean Energy Fuels Corp. (NASDAQ:CLNE). Deutsche Bank & Trust Ag holds 752,164 shares. Dimensional Fund Limited Partnership holds 7.37M shares or 0.01% of its portfolio. New York State Common Retirement Fund reported 107,100 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% of its portfolio in Clean Energy Fuels Corp. (NASDAQ:CLNE) for 8,254 shares. Riggs Asset Managment invested in 0% or 1,000 shares. Wealthtrust invested in 0% or 2,295 shares. Northern Tru Corp owns 1.58 million shares for 0% of their portfolio. Millennium Mgmt Limited Liability Corporation has invested 0.01% of its portfolio in Clean Energy Fuels Corp. (NASDAQ:CLNE). Secor Advisors Lp accumulated 412,408 shares. Eagleclaw Cap Managment Limited Co stated it has 11,000 shares.

Among 2 analysts covering Clean Energy Fuels (NASDAQ:CLNE), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Clean Energy Fuels had 4 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Monday, August 24 by Zacks. Zacks downgraded the stock to “Hold” rating in Monday, August 31 report. The firm has “Mkt Perform” rating given on Tuesday, January 5 by Raymond James.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>